Dr. Mitri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3181 SW Sam Jackson Park Rd
Portland, OR 97239Phone+1 404-839-0083Fax+1 503-494-3257
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2016
Emory University School of MedicineResidency, Internal Medicine, 2010 - 2013
American University of Beirut Faculty of MedicineClass of 2010
Certifications & Licensure
OR State Medical License 2016 - 2025
ID State Medical License 2021 - 2023
GA State Medical License Active through 2013
Clinical Trials
- Olaparib and Durvalumab in Treating Participants With Metastatic Triple Negative Breast Cancer Start of enrollment: 2018 May 03
- Olaparib in Combination With Either Durvalumab, Selumetinib, or Capivasertib or Ceralasertib Alone in Treating Patients With Metastatic Triple Negative Breast Cancer Start of enrollment: 2018 Dec 12
- Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer Start of enrollment: 2021 Jun 07
Publications & Presentations
PubMed
- Author Correction: Dose escalation and expansion cohorts in patients with advanced breast cancer in a Phase I study of the CDK7-inhibitor samuraciclib.R C Coombes, Sacha Howell, Simon R Lord, Laura Kenny, Janine Mansi
Nature Communications. 2025-03-06 - Immunotherapy boosts responses in hormone receptor-positive breast cancers.Zahi Mitri, Karen A Gelmon
Nature Medicine. 2025-02-01 - 3 citationsStrategies for the prevention or reversal of PARP inhibitor resistance.Zahi Mitri, Shaun M Goodyear, Gordon Mills
Expert Review of Anticancer Therapy. 2024-10-01
Press Mentions
New Breast Cancer Approach: Self-DefenseOctober 10th, 2021- Clinical Challenges: Genetic Testing in Metastatic Breast CancerDecember 19th, 2020
- Zahi Mitri, MD, on Tumor Genomics in Metastatic Breast CancerSeptember 15th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
